NCT01218633
- Conditions
- Pancreatic Effects of 9,39-Exendin and 9,36-GLP-1
- Locations
-
- Mayo Clinic Rochester, Minnesota, United States
Clinical trial condition
Pancreatic Effects of 9,39-Exendin and 9,36-GLP-1
Explore clinical trials studying Pancreatic Effects of 9,39-Exendin and 9,36-GLP-1. Study availability and eligibility vary by location and protocol.
1 public trial
0 recruiting studies